These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 16802573)

  • 21. Guidelines for diagnosis, therapy and follow up of Anderson-Fabry disease.
    Kes VB; Cesarik M; Zavoreo I; Soldo-Butković S; Kes P; Basić-Jukić N; Racki S; Jakić M; Delić-Brkljacić D; Jukić Z; Trkanjec Z; Serić V; Solter VV; Bielen I; Basić S; Demarin V; ; ; ;
    Acta Clin Croat; 2013 Sep; 52(3):395-405. PubMed ID: 24558776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neurological complications of Fabry-disease].
    Vastagh I; Constantin T; Kéri A; Rudas G; Fekete G; Bereczki D
    Ideggyogy Sz; 2011 Jan; 64(1-2):29-35. PubMed ID: 21428036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrastructural study of renal involvement in two females with Anderson-Fabry disease.
    Tosoni A; Nebuloni M; Zerbi P; Vago L; Comotti C; Sessa A
    Ultrastruct Pathol; 2005; 29(3-4):203-7. PubMed ID: 16036875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal ultrastructural findings in Anderson-Fabry disease.
    Sessa A; Toson A; Nebuloni M; Pallotti F; Giordano F; Battini G; Maglio A; Meroni M; Calconi G; Bertolone G; Gatti P
    J Nephrol; 2002; 15(2):109-12. PubMed ID: 12018625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anderson-Fabry disease and the heart.
    O'Mahony C; Elliott P
    Prog Cardiovasc Dis; 2010; 52(4):326-35. PubMed ID: 20109602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fabry kidney disease.
    Moran V; Obrador GT; Thadhani R
    Saudi J Kidney Dis Transpl; 2003; 14(3):367-77. PubMed ID: 17657109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fabry disease.
    Schiffmann R
    Pharmacol Ther; 2009 Apr; 122(1):65-77. PubMed ID: 19318041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fabry's disease (alpha-galactosidase-A deficiency): recent therapeutic innovations].
    Germain DP
    J Soc Biol; 2002; 196(2):183-90. PubMed ID: 12360747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fabry disease in hemodialysis patients in southern Brazil: prevalence study and clinical report.
    Porsch DB; Nunes AC; Milani V; Rossato LB; Mattos CB; Tsao M; Netto C; Burin M; Pereira F; Matte U; Giugliani R; Barros EJ
    Ren Fail; 2008; 30(9):825-30. PubMed ID: 18925518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological manifestation of Fabry disease--a case report.
    Demarin V; Kes VB; Bitunjac M; Ivanković M
    Coll Antropol; 2009 Dec; 33 Suppl 2():177-9. PubMed ID: 20120409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Early diagnosis of Fabry disease in children].
    Genoni G; Demarchi I; Bellone S; Petri A; Settanni F; Dondi E; Negro M; Cortese L; Prodam F; Bona G
    Minerva Pediatr; 2011 Oct; 63(5):425-30. PubMed ID: 21946453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fabry disease in Italy: first epidemiologic and collaborative study].
    Ricci R; Castorina M; Di Lillo M; Antuzzi D; Frustaci A; Parini R; Menni F; Furlan F; Burlina A; Burlina A; Catuogno S; Gabrielli O; Burattini I; Borsini W; Buchner S; Ferriozzi S; Spisni C; De Vito R; Di Rocco M; Aricò M; Pistone G; Bongiorno AM; Morrone A; Cavicchi C; Zammarchi E
    Ann Ital Med Int; 2004; 19(4):269-75. PubMed ID: 15678707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy.
    Breunig F; Wanner C
    J Nephrol; 2008; 21(1):32-7. PubMed ID: 18264934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice.
    Rodrigues LG; Ferraz MJ; Rodrigues D; Pais-Vieira M; Lima D; Brady RO; Sousa MM; Sá-Miranda MC
    Neurobiol Dis; 2009 Jan; 33(1):48-56. PubMed ID: 18848893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Psychiatric and neuropsychological signs and symptoms in patients with fabry disease: literature review].
    Müller MJ; Müller KM; Dascalescu A; Whybra C; Baron K; Scheurich A; Mann K; Beck M; Schmidt LG; Fellgiebel A
    Fortschr Neurol Psychiatr; 2005 Nov; 73(11):687-93. PubMed ID: 16283613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular features of Fabry disease: diagnosis of a treatable life-threatening disorder.
    Samiy N
    Surv Ophthalmol; 2008; 53(4):416-23. PubMed ID: 18572058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fabry disease: perspectives of urinary proteomics.
    Cuccurullo M; Beneduci A; Anand S; Mignani R; Cianciaruso B; Bachi A; Capasso G
    J Nephrol; 2010; 23 Suppl 16():S199-212. PubMed ID: 21170881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal profile and fertility in patients with Anderson-Fabry disease.
    Hauser AC; Gessl A; Harm F; Wiesholzer M; Kleinert J; Wallner M; Voigtländer T; Bieglmayer C; Sunder-Plassmann G
    Int J Clin Pract; 2005 Sep; 59(9):1025-8. PubMed ID: 16115176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fabry disease: clinical spectrum and evidence-based enzyme replacement therapy.
    Desnick RJ; Banikazemi M
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S172-85. PubMed ID: 17373219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fabry-Anderson disease: current state of knowledge].
    Vega-Vega O; Pérez-Gutiérrez A; Correa-Rotter R
    Rev Invest Clin; 2011; 63(3):314-21. PubMed ID: 21888295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.